Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DX243 in Age-related Hearing Loss
NCT07637981Phase 2Recruiting
- Sponsor
- Dendrogenix
- Start
- May 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
A Phase 2 trial of DX243 in age-related hearing loss, sponsored by Dendrogenix. Started May 2026; status: recruiting.
02
Drugs
DX243
03
Conditions
age-related hearing loss
Beyond the preview
Go deeper on NCT07637981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07637981.